SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] 8-K: NEWS RELEASE Skystar Bio-Pharmaceutical Reports Second Quarter 2011

[NEWS RELEASE Skystar Bio-Pharmaceutical Reports Second Quarter 2011 Results $9.1 Million Top Line; $0.21 Diluted EPS; Expanded Direct Distribution and Sales Channels XI’AN, CHINA – August 23, 2011 -- - Skystar Bio-Pharmaceutical Company (NASDAQ:SKBI) ("Skystar" or the "Company"), Second Quarter 2011 Highlights · Revenue increases 10% YoY to $9.1 million · Veterinary vaccines totaled $0.4million, up 1.2% YoY · Veterinary]

By | 2016-03-01T05:06:23+00:00 August 23rd, 2011|Categories: Chinese Stocks, SKBI, Webplus ver|Tags: , , , , , |0 Comments
Read More

EVK [Ever-Glory International,] 8-K: (Original Filing)

[FORM 8-K CURRENT REPORT Date of report (Date of earliest event reported): August 23, 2011 (August 19, 2011) EVER-GLORY INTERNATIONAL GROUP, INC. Florida 000-28806 65-0420146 (State or other jurisdiction of incorporation or organization) (Commission File No.) (IRS Employee Identification No.) Ever-Glory Commercial Center, 509 Chengxin Road, Jiangning Development Zone, Nanjing, Jiangsu Province, Peoples Republic of China (8625) 5209-6875 (Issuer Telephone]

By | 2016-03-02T16:26:58+00:00 August 23rd, 2011|Categories: Chinese Stocks, EVK, SEC Original|Tags: , , , , , |0 Comments
Read More

EVK [Ever-Glory International,] 8-K: FORM 8-K CURRENT REPORT Date of report (Date

[FORM 8-K CURRENT REPORT Date of report (Date of earliest event reported): August 23, 2011 (August 19, 2011) EVER-GLORY INTERNATIONAL GROUP, INC. Florida 000-28806 65-0420146 (State or other jurisdiction of incorporation or organization) (Commission File No.) (IRS Employee Identification No.) Ever-Glory Commercial Center, 509 Chengxin Road, Jiangning Development Zone, Nanjing, Jiangsu Province, Peoples Republic of China (8625) 5209-6875 (Issuer Telephone]

By | 2016-03-02T16:27:39+00:00 August 23rd, 2011|Categories: Chinese Stocks, EVK, Webplus ver|Tags: , , , , , |0 Comments
Read More

SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] 8-K: (Original Filing)

[NEWS RELEASE Skystar Bio-Pharmaceutical Reports Second Quarter 2011 Results $9.1 Million Top Line; $0.21 Diluted EPS; Expanded Direct Distribution and Sales Channels XI’AN, CHINA – August 23, 2011 -- - Skystar Bio-Pharmaceutical Company (NASDAQ:SKBI) ("Skystar" or the "Company"), Second Quarter 2011 Highlights · Revenue increases 10% YoY to $9.1 million · Veterinary vaccines totaled $0.4million, up 1.2% YoY · Veterinary]

By | 2016-03-01T05:04:07+00:00 August 23rd, 2011|Categories: Chinese Stocks, SEC Original, SKBI|Tags: , , , , , |0 Comments
Read More

SOL [ReneSola] 6-K: (Original Filing)

[ReneSola Announces US$100 Million Share Repurchase Program JIASHAN, China, August 22, 2011 – Under the program, the Company may, from time to time, for a limited Mr. Xianshou Li, ReneSola’s chief executive officer and director, commented, “At present, we believe our shares are undervalued. Despite relatively weak capital markets and a challenging solar market, we are confident in the long-term] [RENESOLA LTD No. 8 Baoqun Road, YaoZhuang Jiashan, Zhejiang 314117 People’s Republic of China x ¨ Form 20-F ¨ x Yes N/A 82- RENESOLA LTD Xianshou Li Xianshou Li Chief Executive Officer]

By | 2016-03-27T12:21:34+00:00 August 23rd, 2011|Categories: Chinese Stocks, SEC Original, SOL|Tags: , , , , , |0 Comments
Read More

SOL [ReneSola] 6-K: ReneSola Announces US$100 Million Share Repurchase Program JIASHAN,

[ReneSola Announces US$100 Million Share Repurchase Program JIASHAN, China, August 22, 2011 – Under the program, the Company may, from time to time, for a limited Mr. Xianshou Li, ReneSola’s chief executive officer and director, commented, “At present, we believe our shares are undervalued. Despite relatively weak capital markets and a challenging solar market, we are confident in the long-term] [RENESOLA LTD No. 8 Baoqun Road, YaoZhuang Jiashan, Zhejiang 314117 People’s Republic of China x ¨ Form 20-F ¨ x Yes N/A 82- RENESOLA LTD Xianshou Li Xianshou Li Chief Executive Officer]

By | 2016-03-27T12:23:17+00:00 August 23rd, 2011|Categories: Chinese Stocks, SOL, Webplus ver|Tags: , , , , , |0 Comments
Read More

NPD [China Nepstar Chain Drugstore] 6-K: (Original Filing)

[China Nepstar Chain Drugstore Announces Share Repurchase Program China Nepstar Chain Drugstore Ltd. (NYSE: NPD) SHENZHEN, China, Aug. 23, 2011 /PRNewswire-Asia-FirstCall/ — The repurchases will be made on the open market at prevailing market prices or in block trades and subject to restrictions relating to volume, price and timing. The timing and extent of any purchases will depend upon market] [China Nepstar Chain Drugstore Reports Second Quarter 2011 Financial Results - Same Store Sales Increase 9.8% - Shenzhen, China, August 23, 2011 Financial Highlights For the quarter ended June 30, 2011: • Revenue increased by 7.3% to RMB606.6 million (US$93.8 million), compared to revenue of RMB565.2 million in the second quarter of 2010. • Same store sales increased by 9.8%] [China Nepstar Chain Drugstore Announces Management Change SHENZHEN, China, Aug. 23, 2011 /PRNewswire-Asia-FirstCall/ — China Nepstar Chain Drugstore Ltd. (NYSE: NPD) (“Nepstar” or the “Company”), the largest drugstore chain in China based on the number of directly operated stores, today announced the resignation of Mr. Jason Xinghua Wu as the Company’s Chief Executive Officer, effective today, for personal reasons. Mr.]

By | 2016-03-07T05:24:37+00:00 August 23rd, 2011|Categories: Chinese Stocks, NPD, SEC Original|Tags: , , , , , |0 Comments
Read More
Skip to toolbar